본문 바로가기
bar_progress

Text Size

Close

Is the Era of Performing Endoscopy at Home Finally Here?

Those who applied for hit the upper limit price in just one day! Achieved 32% profit!

Congratulations to everyone who applied for the free trial. ^^


※ For those who missed the “COVID-19 treatment,” it’s okay. We are going out big once again.

※ Finally starting. Korea Union Pharmaceutical (080720) follow-up stock hits the upper limit price on Monday. ※


▶▶ Starting huge ‘upper limit price’ on October 12 related to US capsule endoscopy home use approval! ‘ㅇㅇㅇㅇㅇ’ related stock! ▶ Apply for free trial ◀


The US FDA has allowed CapsoVision’s capsule small bowel endoscope CapsoCam Plus to be used at home during the COVID-19 pandemic!!

CapsoCam Plus requires no additional external equipment, and after swallowing, it is retrieved 8 to 12 hours later and sent to the clinic, where it is disinfected during use!!



▶▶ Heading straight ‘up’ on Monday. Moving fast. Beneficiary stock related to US capsule endoscopy home use approval! Don’t miss it [Apply now for ‘US capsule endoscopy home use approval’ related stocks]


“It was so difficult to trade stocks alone.” So I thought to get help from an expert and first applied for a 3-day free trial! Wow! Experts really are different. I am still receiving the service now, and looking back, I think it was a great decision. Thank you.

(VIP government official Park Han-young, 43 years old member)



▶▶ “October 12 upper limit price” offered only until today and then closed. [Receive stocks related to ‘US capsule endoscopy home use approval’!] ▶ Receive stocks ◀


Think of this as the last chance. If you miss this opportunity, you have to give up.

Exactly on “October 12” it will explode! Don’t miss it and regret it, just buy even with 100,000 KRW!


▶▶ Only 10 people! “Monday upper limit price”! ▶ Receive now ◀


※ First-come, first-served 10 people only! Both early and late rounds are over. The hero of the last injury time winning goal ※


[Today’s stocks of interest]

#ShinpoongPharmaceutical #HyundaiPharmaceutical #AprogenPharmaceutical #MyungmoonPharmaceutical #Bionex


※ This content is unrelated to Asia Economy’s editorial direction, and all responsibility lies with the information provider.


© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Special Coverage


Join us on social!

Top